Xu Xiu

Jian Zhixiang

General Surgery Department

Academic Leader in General Surgery, Director of the Surgical Center, PhD Supervisor, Chief Physician, Doctor of Medicine (MD), Vice President, Professor

Professional fields:

Advanced minimally invasive hepatobiliary and pancreatic surgery, including single-port laparoscopic cholecystectomy, laparoscopic hepatectomy and indocyanine green fluorescence-guided laparoscopic liver resection.

He has over 30 years of general surgery experience at Guangdong Provincial People's Hospital, where he formerly directed Hepatobiliary Surgery, General Surgery and the Surgical Center. He has extensive expertise in hepatobiliary and pancreatic surgery, particularly the surgical treatment of benign and malignant liver, gallbladder and pancreatic tumors, complex intrahepatic and extrahepatic bile duct stones, and general surgical conditions. He has developed multiple minimally invasive procedures, including single-port laparoscopic cholecystectomy, laparoscopic hepatectomy and indocyanine green fluorescence-guided laparoscopic liver resection, with internationally advanced results. He has led multiple projects funded by the National Natural Science Foundation of China, the Guangdong Natural Science Foundation, the Guangdong Science and Technology Program and major Guangzhou collaborative innovation programs. He has published over 140 Chinese-language articles and more than 80 SCI-indexed papers. His honors include the Guangdong Physician Award, Outstanding Physician of Guangzhou and Prominent Physician of the Lingnan Region. He completed advanced training at the Hanse Hospital in Stralsund, Germany, and Beth Israel Hospital in New York. He chairs the Surgeons Branch of the Guangdong Medical Doctor Association; serves on national, provincial and international surgical committees, including pancreatic, hepatobiliary and multidisciplinary treatment groups; and is a healthcare expert for senior officials in Guangdong Province.

Ou Junwen

Anti-Aging Medical Center / Nutrition Department

Director of the Anti-Aging Medical Center and International Health Management Center, Master's Supervisor, Doctor of Medicine (MD), Vice President

Professional fields:

Proficient in internationally certified adjuvant tumor therapies such as chelation therapy, hyperthermia, ozone therapy and insulin potentiation therapy. Specializes in integrative Western and traditional Chinese medicine management of malignant tumors, coronary heart disease, diabetes, irritable bowel syndrome, chronic fatigue syndrome, uncomplicated obesity and sarcopenia

Dr. Ou previously worked in the Department of Geriatrics at Barnsley District General Hospital in the United Kingdom and has long been engaged in clinical practice and research in comprehensive cancer treatment and the prevention and management of aging. Key academic achievements: As first or corresponding author, Dr. Ou has published SCI-indexed articles in leading journals including Journal of Advanced Research, Journal of Thoracic Oncology, and Free Radical Biology and Medicine. One first-author article had an impact factor of 12.8, with a cumulative impact factor of 134. Dr. Ou has led 15 research projects, including a General Program of the Natural Science Foundation of Guangdong Province, with total research funding exceeding RMB 3 million; serves as a reviewer for Aging, Frontiers in Molecular Biosciences, and Integrative Cancer Therapies; has contributed to four Chinese medical guidelines or consensus statements; and has served as editor-in-chief or contributing author of six monographs. Honors and professional appointments include: Guangzhou High-Level Medical Talent; Outstanding Medical Teaching and Research Professional at Jinan University; Expert Receiving a Special Government Allowance from Panyu District; member of the American Society of Clinical Oncology (ASCO); standing member of the Cancer Hyperthermia Expert Committee of the Chinese Society of Clinical Oncology (CSCO); standing member of the Cancer Nutrition Professional Committee of the Chinese Anti-Cancer Association; vice chair of the Hospital Nutrition Management Professional Committee of the Guangdong Hospital Association; and standing member of the Multidisciplinary Cancer Care Working Committee of the Guangdong Medical Doctor Association.

Hu Zhiqi

Cosmetic Surgery Center

Postdoctoral Co-Supervisor, PhD Supervisor, Chief Physician, Level II Professor

Professional fields:

Scar revision, eyelid and periorbital surgery, rhinoplasty, breast surgery, management of complex cases and complications, hair transplantation, late-stage facial paralysis and facial rejuvenation.

With nearly 40 years of experience in plastic, microsurgical and cosmetic surgery, he is a Distinguished Professor and academic leader in plastic and cosmetic surgery at Nanfang Hospital of Southern Medical University and Chief Consultant to the Cosmetic Surgery Center at Clifford Hospital. He chairs the Plastic Surgery Expert Committee for Graduate Medical Education of the Chinese Medical Doctor Association. He has extensive experience in facial and body aesthetic surgery, post-burn and post-traumatic scar reconstruction and congenital deformities, with particular strength in complex case management and microsurgery. He developed a new temporalis muscle, temporal fascia and galeal transfer procedure for late-stage facial paralysis. He has led six projects funded by the National Natural Science Foundation of China; received five awards as first author, including First Prizes of the Guangdong Science and Technology Progress Award and Guangdong Medical Science and Technology Award; led development of Chinese clinical guidelines for androgenetic alopecia; and published 117 SCI-indexed articles with a combined impact factor of 647.893. He holds senior leadership roles in national and Guangdong plastic surgery, aesthetic medicine, hair medicine and quality-control organizations and serves as deputy editor-in-chief of the Chinese Journal of Aesthetic and Plastic Surgery and Plastic and Aesthetic Research.

Cai Qichun

Oncology Department

Director of the Oncology Center, Academic Leader, Doctor of Oncology (DOnc), Chief Physician

Professional fields:

Chemotherapy, targeted therapy and immunotherapy for common cancers, including malignant lymphoma, head and neck cancer, lung cancer, gastrointestinal cancer and gynecological cancer.

She earned her medical degree from Sun Yat-sen University and master's and doctoral degrees in oncology from Sun Yat-sen University Cancer Center. After graduation, she worked at the Cancer Center of Guangdong Provincial People's Hospital and joined Clifford Hospital in 2018. She is deputy secretary-general and executive member of the Chinese Breast Disease Prevention and Treatment Committee; deputy chair of the Guangdong Academic Committee for Precision and Comprehensive Cancer Treatment; an executive member of the Guangdong Clinical Medicine Society; and a member of the Hematologic Oncology Committee of the Guangdong Anti-Cancer Association. Her research focuses on the tumor immune microenvironment. In 2002, she proposed a theory of whole-system cancer immunotherapy aimed at restoring and strengthening antitumor immunity. She specializes in chemotherapy, targeted therapy and immunotherapy for malignant lymphoma, head and neck cancer, lung cancer, gastrointestinal cancer, gynecological cancer and other common tumors, as well as complex cancer cases. Her clinical and research work in NK/T-cell lymphoma is internationally advanced. She has published more than 40 articles in journals including Nature Medicine, participated in seven provincially funded or higher-level projects, and contributed to multiple international and domestic clinical drug trials.

Liu Qiuhua

Radiation Therapy Department

Director of the Radiation Oncology Center, Chief Physician

Professional fields:

Stereotactic precision treatment of benign and malignant diseases of the nervous system and other body systems; CyberKnife therapy; and selected stereotactic or functional procedures for substance dependence, psychiatric disorders, Parkinson's disease and cerebral palsy.

He graduated in clinical medicine from Guangxi Medical University and holds certification in the US CyberKnife system, China's Gamma Knife/X-knife system and chief-level surgery practice. He has completed advanced training in the United States, Taiwan and major hospitals across China and has systematic expertise in stereotactic precision treatment, with experience in several thousand cases. He has participated in multiple Chinese and international research projects, contributed to the world's first Chinese-language CyberKnife monograph, published dozens of articles, and pioneered peripheral nerve reduction surgery for migraine and post-stroke sequelae in China. He specializes in stereotactic precision treatment of benign and malignant diseases of the nervous system and other body systems, CyberKnife therapy, and selected stereotactic or functional procedures for substance dependence, psychiatric disorders, Parkinson's disease and cerebral palsy. He has been invited by hospitals in Guangdong, Hunan, Hainan and Jiangxi to provide instruction in new surgical techniques.

Ouyang Ping

VIP Medical Center

Director of the VIP Medical Center, Chief Physician, Doctor of Medicine (MD), Postdoctoral Fellow

Professional fields:

Diagnosis and treatment of common cardiovascular conditions- including coronary heart disease, hypertension, hyperlipidemia, hyperuricemia, arrhythmias, and heart failure- and application of medicine-food homology principles in health management for older adults.

He formerly served as Director of the Health Management Center at Nanfang Hospital of Southern Medical University and Deputy Director of the Institute of Health at Southern Medical University. He chairs the Precision Health Management Branch of the Guangdong Precision Medicine Application Society and holds senior leadership and expert roles in national, Guangdong, and Guangzhou organizations for health management; chronic disease; behavioral medicine; integrative psychocardiology; hypertension; emergency management; medical science communication; and quality control. He serves on editorial boards, standards committees, and medical appraisal expert panels at the provincial and municipal levels.

Zhang Hongyu

Oncology Department

Associate Chief Physician

Professional fields:

Diagnosis of abdominal malignant tumors such as colorectal, gastric and pancreatic cancer, and gynecological and breast malignant tumors; chemotherapy, targeted and immunotherapy for common malignant tumors; psychological counseling and nutritional rehabilitation guidance for patients.

With over 20 years of clinical experience in medical oncology, she specializes in the diagnosis of abdominal and gynecological/breast malignant tumors and systemic anticancer therapy. She participated in systematic traditional Chinese medicine knowledge and skills training for non-TCM physicians in Guangdong traditional Chinese medicine hospitals from 2014 to 2016, and completed advanced training in the Department of Internal Medicine at Sun Yat-sen University Cancer Center in 2015. Since 2017, she has led a team independently to be fully responsible for the full-course management of patients and emergency management of critically ill patients. She has served as Deputy Director of the Oncology Department since June 2020 and Director of the Medical Oncology Department since April 2022, promoting a comfortable and warm oncology care model and building a new integrative Chinese and Western medicine oncology team providing holistic physical, mental and spiritual care.

Lin Zhiqiang

Pediatrics Department

Deputy Director of the Pediatrics Center, Associate Chief Physician

Professional fields:

Diagnosis and treatment of pediatric endocrine and metabolic disorders, including growth and developmental delay, short stature, diabetes and thyroid dysfunction.

He graduated from the Department of Pediatrics at Xinxiang Medical University. He previously taught pediatrics and infectious diseases at Sanquan College of Xinxiang Medical University and served on the Pediatrics Expert Committee of the Xinxiang Medical Association. With over 30 years of clinical pediatric experience, he is proficient in common pediatric respiratory and digestive diseases and specializes in endocrine and metabolic disorders, including growth and developmental delay, short stature, diabetes and thyroid dysfunction. He has received one Xinxiang Science and Technology Progress Award and published over 10 articles.

Shi Jianbo

Otolaryngology (ENT) Department

Academic Leader, Chief Physician, Professor, PhD Supervisor

Professional fields:

Refractory sinusitis, sinonasal inverted papilloma, juvenile nasopharyngeal angiofibroma, cerebrospinal fluid rhinorrhea, skull-base tumors, optic nerve injury, orbital hypertension, chronic dacryocystitis and orbital tumors.

Professor Shi is an Honorary Chief Expert in rhinology at the Department of Otolaryngology, First Affiliated Hospital of Sun Yat-sen University. He is an executive member of the International Rhinologic Society; an executive member of the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Doctor Association; deputy leader of the Rhinologic Surgery Group of the Chinese Society of Otolaryngology-Head and Neck Surgery; an editorial board member and deputy leader of the rhinology review group of the Chinese Journal of Otorhinolaryngology Head and Neck Surgery; and a jointly appointed professor at Zhongshan Ophthalmic Center, Sun Yat-sen University. He has been recognized as a Distinguished Physician of Sun Yat-sen University, a Prominent Physician of the Lingnan Region, and a nationally renowned otolaryngologist-head and neck surgeon, and has been ranked among China's top 10 endoscopic sinus surgeons. He trained under Professors Shen Xuerong, Xu Jintang and Xu Geng and was among the earliest specialists in China to conduct clinical research in endoscopic sinus surgery. He is an expert in endoscopic sinus, rhinologic-orbital and skull-base surgery and has independently performed over 8,000 endoscopic procedures. He has professional expertise in refractory sinusitis, sinonasal inverted papilloma, juvenile nasopharyngeal angiofibroma, cerebrospinal fluid rhinorrhea, skull-base tumors, optic nerve injury, orbital hypertension, chronic dacryocystitis and intraorbital tumors.

Cui Dongming

General Surgery Department

Chief Physician, Professor, Director of General Surgery Department

Professional fields:

He is proficient in diagnosis and treatment of gastrointestinal, thyroid, breast, abdominal hernia, hepatobiliary, pancreatic and splenic diseases. Proficient in standardized treatment of benign and malignant tumors of the gastrointestinal tract, thyroid and breast, especially laparoscopic precise minimally invasive surgery

He serves as Standing Member of the Minimally Invasive Specialty Committee of General Surgery of Guangdong Provincial Association of Integrated Traditional Chinese and Western Medicine, Standing Member of the Working Committee on Multidisciplinary Diagnosis and Treatment Model of Tumors of Guangdong Medical Doctor Association, Member of the Colorectal Cancer and Gastric Cancer Specialty Committees of Chinese Anti-Cancer Association, and Member of the Thyroid and Breast Specialists Branch of Guangdong Medical Doctor Association. With over 20 years of clinical, teaching and research experience in general surgery, he is proficient in standardized treatment of benign and malignant tumors of the gastrointestinal tract, thyroid and breast, and especially skilled in laparoscopic precise minimally invasive surgery, including laparoscopic radical gastrectomy, laparoscopic radical resection of colorectal cancer (ultra-low anus-preserving surgery), laparoscopic weight loss surgery, endoscopic radical thyroidectomy (standardized cervical lymph node dissection), radical mastectomy, laparoscopic tension-free hernia repair, hepatobiliary pancreatic splenic tumor resection and minimally invasive treatment of hepatobiliary stones. He has published more than 20 core journal papers and led and participated in multiple research projects.